Reminyl News and Research

RSS
Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Dementia needs early diagnosis: Report

Dementia needs early diagnosis: Report

Shire reports total revenues of $3,008 million for 2009

Shire reports total revenues of $3,008 million for 2009

Shire announces third quarter 2009 financial results

Shire announces third quarter 2009 financial results

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Bradycardia more likely in patients taking cholinesterase inhibitors

Bradycardia more likely in patients taking cholinesterase inhibitors

Dementia drugs Aricept, Exelon and Reminyl may put some patients at risk

Dementia drugs Aricept, Exelon and Reminyl may put some patients at risk

Furore over who gets Alzheimer's drug in the UK

Furore over who gets Alzheimer's drug in the UK

Brits unable to access Alzheimer's drugs

Brits unable to access Alzheimer's drugs

New 'patch' drug therapy for Alzheimer's has fewer side effects

New 'patch' drug therapy for Alzheimer's has fewer side effects

Concern over decision that new Alzheimer drugs only available for advanced disease

Concern over decision that new Alzheimer drugs only available for advanced disease

UK medical watchdog wants more proof on value of Alzheimer's drugs

UK medical watchdog wants more proof on value of Alzheimer's drugs

Decision to cut Alzheimer's drugs challenged

Decision to cut Alzheimer's drugs challenged

Health authorities reviewing scientific data from trials evaluating Alzheimer's treatment, Reminyl

Health authorities reviewing scientific data from trials evaluating Alzheimer's treatment, Reminyl

Dementia patients receiving long-term treatment with Reminyl may be able to stay at home for longer compared

Dementia patients receiving long-term treatment with Reminyl may be able to stay at home for longer compared

Trial of new type of drug that attacks amyloid

Trial of new type of drug that attacks amyloid

Warning on Alzheimer drug mix up

Warning on Alzheimer drug mix up

Canadian Alzheimer Society responds to donepezil study

Canadian Alzheimer Society responds to donepezil study

Alzheimer’s Society expresses concern over new study on dementia drug effectiveness, published in The Lancet

Alzheimer’s Society expresses concern over new study on dementia drug effectiveness, published in The Lancet

Research into Chinese herbal medicine Qian Ceng Ta may help Alzheimer’s

Research into Chinese herbal medicine Qian Ceng Ta may help Alzheimer’s

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.